bioAffinity Technologies, Inc. (BIAF)
Official siteHEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ
Market Cap: $4.00M
Last updated: Nov 17, 2026 at 11:04 AM ET
Performance (10Y)
Key Metrics
Technical Indicators Dashboard
As of Nov 16, 2026, the price is 60.7% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 30.4, in the neutral range between 30 and 70.
Moving Averages
MACD
ADX
Aroon & PSAR
Bollinger Bands
RSI (14-Day)
Momentum Oscillators
Volatility Measures
Volume Flow
Volume Metrics
Pivot Points
Advanced Oscillators
Financial Performance
Related GNG Research
No research available
Be the first to write about BIAF
News
BIAF Valuation
BIAF Profitability: Margins, ROIC and FCF
bioAffinity Technologies (BIAF) has a gross margin of 100.0%, an operating margin of -246.1% and a net margin of -278.9%. It posts -376.1% ROIC and a -235.9% FCF margin.
- Gross margin
- 100.0%
- Operating margin
- -246.1%
- Net margin
- -278.9%
- ROIC
- -376.1%
- ROE
- -240.5%
- FCF margin
- -235.9%
- FCF yield
- -727.1%
bioAffinity Technologies Competitors
The companies most similar to bioAffinity Technologies (BIAF) include iSpecimen, MDxHealth SA and Bioatla.
Sector: Healthcare
Companies most similar to bioAffinity TechnologiesBIAF Bull Case vs Bear Case
Bear case
- BIAF has a -278.9% net profit margin.
- BIAF beat EPS estimates in 12.5% of its last 8 reported quarters.
- BIAF's quarterly revenue changed -26.0% year over year.
BIAF Earnings: Beat Rate
bioAffinity Technologies (BIAF) beat the EPS estimate in 1 of the 8 most recent quarters that had an estimate (12.5%). Its next report is expected on Mar 11, 2027.
- Beat rate
- 1 of 8 quarters (12.5%)
- Average surprise
- -36.9%
BIAF Earnings Date
BIAF reports Mar 11, 2027. The date is estimated.
BIAF ETF Holders
GNG tracks 1 ETF that holds BIAF.
- Vanguard Extended Market Index Fund ETF Shares (VXF), <0.01% of the fund
Updated Nov 6, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology
Frequently Asked Questions About BIAF
When does BIAF report earnings?
bioAffinity Technologies, Inc. (BIAF) is expected to report earnings on Mar 11, 2027.
Does BIAF pay dividends?
bioAffinity Technologies, Inc. (BIAF) does not currently pay a regular dividend.
What is BIAF's market cap?
bioAffinity Technologies, Inc. (BIAF) has a market capitalization of $4.00M with a current stock price of $2.00.
BIAF pages: Overview, Earnings, Financials, Competitors
Get full access to GNG Research
Create a free account to access portfolio tracking, advanced tools, and more.